Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: A novel approach for the treatment of atrial fibrillation

Journal of International Medical Research

Volumn 36, Issue 3, 2008, Pages 537-543

  Qian, Y J ^a   Xiao, Xi Jun ^a   Yuan, H S ^a   Tang, H ^a   Shao, H Z ^a   Wei, D M ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Amiodarone; Angiotensin converting enzyme inhibitor; Atrial fibrillation; Captopril; Pharmacological cardioversion; Prosthetic mitral valve replacement; Simvastatin

Indexed keywords

AMIODARONE; CAPTOPRIL; SIMVASTATIN;

ADULT; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; OUTPATIENT CARE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM;

EID: 45149126673     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600319     Document Type: Article

References (20)

1. Benjamin EJ, Wolf PA, D'Agostino RB, et al: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
2. Lee JW, Park NH, Choo SJ, et al: Surgical outcome of the maze procedure for atrial fibrillation in mitral valve disease: rheumatic versus degenerative. Ann Thorac Surg 2003; 75: 57-61.
3. Lim E, Barlow CW, Hosseinpour AR, et al: Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001; 104: 159-163.
4. Khan IA: Pharmacological cardioversion of recent onset atrial fibrillation. Eur Heart J 2004; 25: 1274-1276.
5. Horstkotte D: Arrhythmias in the natural history of mitral stenosis. Acta Cardiol 1992; 47: 105-113.
6. Shiga T: Atrial fibrillation and rheumatic valvular heart disease: usefulness of very-low-dose amiodarone. Chin Med J (Engl) 2006; 119: 2027-2029.
7. Sanders P, Morton JB, Davidson NC, et al: Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003; 108: 1461-1468.
8. Li DS, Shinagawa K, Pang L, et al: Effects of angiotensin-converting enzyme inhibition on the development of the citrial fibrillation substrate in dogs with ventricular tachypocing-induced congestive heart failure. Circulation 2001; 104: 2608-2614.
9. Cha TJ, Ehrlich JR, Zhang L, et al: Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004; 109: 412-418.
10. Allessie MA: Atrial electrophysiologic remodeling: another vicious circle? J Cardiovasc Electrophysiol 1998; 9: 1378-1393.
11. Nattel S, Shiroshita-Takeshita A, Cardin S, et al: Mechanisms of atrial remodeling and clinical relevance. Curr Opin Cardiol 2005; 20: 21-25.
12. Franz MR, Karasik PL, Li C, et al: Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997; 30: 1785-1792.
13. Blaauw Y, Crijns HJ: Atrial fibrillation: insights from clinical trials and novel treatment options. J Intern Med 2007; 262: 593-614.
14. Blanchard L, Collard CD: Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins. Curr Opin Anaesthesiol 2007; 20: 53-56.
15. Chevalier P, Durand-Dubief A, Burri H, et al: Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41: 255-262.
16. Kochiadakis GE, Igoumenidis NE, Marketou ME, et al: Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative placebo controlled study. Heart 2000; 84: 251-257.
17. Kochiadakis GE, Igoumenidis NE, Hamilos ME, et al: A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Am J Cardiol 2007; 99: 1721-1725.
18. Roy D, Talajic M, Dorian P, et al: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342: 913-920.
19. Singh SN, Fletcher RD, Fisher SG, et al: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995; 333: 77-82.
20. Cairns JA, Connolly SJ, Roberts R, et al: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349: 675-682.